KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Debt to Equity (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Debt to Equity for 7 consecutive years, with $0.79 as the latest value for Q4 2025.

  • Quarterly Debt to Equity rose 16.76% to $0.79 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.79 through Dec 2025, up 16.76% year-over-year, with the annual reading at $0.79 for FY2025, 16.76% up from the prior year.
  • Debt to Equity hit $0.79 in Q4 2025 for GoodRx Holdings, down from $0.81 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.04 in Q1 2024 to a low of $0.68 in Q4 2024.
  • Historically, Debt to Equity has averaged $0.81 across 5 years, with a median of $0.8 in 2021.
  • Biggest five-year swings in Debt to Equity: surged 32.92% in 2024 and later fell 27.59% in 2025.
  • Year by year, Debt to Equity stood at $0.8 in 2021, then increased by 1.44% to $0.81 in 2022, then increased by 6.56% to $0.86 in 2023, then decreased by 21.24% to $0.68 in 2024, then increased by 16.76% to $0.79 in 2025.
  • Business Quant data shows Debt to Equity for GDRX at $0.79 in Q4 2025, $0.81 in Q3 2025, and $0.76 in Q2 2025.